Turn Therapeutics (TTRX) announces that its common stock is scheduled to commence trading, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effective by the U.S. Securities and Exchange Commission September 30, 2025. Clear Street served as financial advisor to the company. Davis, Polk, and Wardwell acted as legal counsel.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.